Cencora
CENCORA, INC.
Key figures
Period Oct 2024 to Sep 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$321.3B
Operating marginCalculated
0.8%
Net assets to total assetsCalculated
2.0%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
0.8%
Growth (revenue, 4-year average)
★★★★☆position among all companies
10.7%
Capital efficiency
★★★★★position among all companies
103.1%
Revenue and profit
Performance, financial position and capital allocation
Cencora
Recent performance trends
Cencora
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$214.0 billion | US$238.6 billion | US$262.2 billion | US$294.0 billion | US$321.3 billion |
| Operating income | US$2.4 billion | US$2.4 billion | US$2.3 billion | US$2.2 billion | US$2.6 billion |
| Net income | US$1.5 billion | US$1.7 billion | US$1.7 billion | US$1.5 billion | US$1.6 billion |
| Total assets | US$57.3 billion | US$56.6 billion | US$62.6 billion | US$67.1 billion | US$76.6 billion |
| Shareholders' equity | US$0.2 billion | US$-0.2 billion | US$0.5 billion | US$0.6 billion | US$1.5 billion |
| Net cash provided by (used in) operating activities | US$2.7 billion | US$2.7 billion | US$3.9 billion | US$3.5 billion | US$3.9 billion |
| Net cash provided by (used in) investing activities | US$-6.1 billion | US$-0.4 billion | US$-2.6 billion | US$-0.6 billion | US$-5.0 billion |
| Net cash provided by (used in) financing activities | US$2.0 billion | US$-1.8 billion | US$-2.2 billion | US$-2.3 billion | US$2.2 billion |
| Cash and cash equivalents | US$2.5 billion | US$3.4 billion | US$2.6 billion | US$3.1 billion | US$4.4 billion |
Revenue scale in the same industry
Cencora
Wholesale (nondurable goods): 16 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 McKESSONFY Mar 2026 US$403.4B
- 2 CencoraThis companyFY Sep 2025 US$321.3B
- 3 Cardinal HealthFY Jun 2026 US$254.2B
- 4 SyscoFY Jun 2026 US$84.6B
- … 12 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.7 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$4.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$2.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-5.0 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$3.9 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$1.1 billion | Consolidated | Disclosed |
| Dividends paid | US$0.4 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$1.7 billion | Consolidated | Disclosed |
| Non-controlling interests | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$1.5 billion | Consolidated | Disclosed |
| Net sales | US$321.3 billion | Consolidated | Disclosed |
| Operating income | US$2.6 billion | Consolidated | Disclosed |
| Net income | US$1.6 billion | Consolidated | Disclosed |
| Total assets | US$76.6 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.4 billion | Consolidated | Disclosed |
| Operating margin | 0.8% | Consolidated | Calculated |
| Net assets to total assets | 2.0% | Consolidated | Calculated |
| Net margin | 0.5% | Consolidated | Calculated |
| Return on equity | 103.1% | Consolidated | Calculated |